An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder.
Discov Ment Health
; 3(1): 2, 2023 Jan 05.
Article
en En
| MEDLINE
| ID: mdl-37861876
ABSTRACT
Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition characterized by developmentally inappropriate symptoms of inattention and/or hyperactivity/impulsivity, which leads to impairments in the social, academic, and professional contexts. ADHD diagnosis relies solely on clinical assessment based on symptom evaluation and is sometimes challenging due to the substantial heterogeneity of the disorder in terms of clinical and pathophysiological aspects. Despite the difficulties imposed by the high complexity of ADHD etiology, the growing body of research and technological advances provide good perspectives for understanding the neurobiology of the disorder. Such knowledge is essential to refining diagnosis and identifying new therapeutic options to optimize treatment outcomes and associated impairments, leading to improvements in all domains of patient care. This review is intended to be an updated outline that addresses the etiological and neurobiological aspects of ADHD and its treatment, considering the impact of the "omics" era on disentangling the multifactorial architecture of ADHD.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Discov Ment Health
Año:
2023
Tipo del documento:
Article
País de afiliación:
Brasil